Vaxcyte issues $575M 1.50% convertible notes
Vaxcyte completed concurrent financing, issuing $575 million of 1.50% convertible senior notes due 2032 and entering related underwriting and indenture arrangements.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.